Biorestorative Therapies (BRTX) Competitors $1.83 +0.27 (+17.24%) Closing price 08/28/2025 03:59 PM EasternExtended Trading$1.80 -0.02 (-1.31%) As of 08/28/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BRTX vs. BMGL, MRAI, CCM, BGLC, SSY, MGRX, ACON, ATIP, DHAC, and VSEEShould you be buying Biorestorative Therapies stock or one of its competitors? The main competitors of Biorestorative Therapies include Basel Medical Group (BMGL), Marpai (MRAI), Concord Medical Services (CCM), BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), Mangoceuticals (MGRX), Aclarion (ACON), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), and VSee Health (VSEE). These companies are all part of the "healthcare" industry. Biorestorative Therapies vs. Its Competitors Basel Medical Group Marpai Concord Medical Services BioNexus Gene Lab SunLink Health Systems Mangoceuticals Aclarion ATI Physical Therapy Digital Health Acquisition VSee Health Biorestorative Therapies (NASDAQ:BRTX) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk. Which has preferable earnings and valuation, BRTX or BMGL? Basel Medical Group has lower revenue, but higher earnings than Biorestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiorestorative Therapies$400K36.49-$8.98M-$1.27-1.44Basel Medical GroupN/AN/AN/AN/AN/A Do insiders & institutionals hold more shares of BRTX or BMGL? 69.4% of Biorestorative Therapies shares are owned by institutional investors. 30.8% of Biorestorative Therapies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer BRTX or BMGL? In the previous week, Biorestorative Therapies and Biorestorative Therapies both had 1 articles in the media. Basel Medical Group's average media sentiment score of 1.88 beat Biorestorative Therapies' score of 0.94 indicating that Basel Medical Group is being referred to more favorably in the news media. Company Overall Sentiment Biorestorative Therapies Positive Basel Medical Group Very Positive Is BRTX or BMGL more profitable? Basel Medical Group has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -1,772.40%. Basel Medical Group's return on equity of 0.00% beat Biorestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Biorestorative Therapies-1,772.40% -137.00% -88.31% Basel Medical Group N/A N/A N/A SummaryBasel Medical Group beats Biorestorative Therapies on 4 of the 7 factors compared between the two stocks. Get Biorestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBiorestorative TherapiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.45M$3.10B$5.78B$9.79BDividend YieldN/A2.26%3.95%4.02%P/E Ratio-1.4421.0831.2626.59Price / Sales36.49361.89431.16158.34Price / CashN/A44.6737.7359.36Price / Book3.008.0910.046.68Net Income-$8.98M-$54.08M$3.27B$265.59M7 Day Performance19.54%-0.41%1.34%0.66%1 Month Performance19.54%6.23%6.13%2.64%1 Year Performance12.21%10.45%41.90%22.36% Biorestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBiorestorative Therapies2.342 of 5 stars$1.83+17.2%N/A+8.9%$12.45M$400K-1.447High Trading VolumeBMGLBasel Medical GroupN/A$1.91-8.6%N/AN/A$35.24MN/A0.0036Lockup ExpirationGap DownMRAIMarpaiN/A$1.45+2.1%N/A+186.9%$25.04M$34.87M-0.55150News CoverageCCMConcord Medical Services0.4798 of 5 stars$5.44+2.3%N/A-16.5%$23.63M$383.96M0.00970News CoverageBGLCBioNexus Gene Lab0.2337 of 5 stars$5.32flatN/A+25.9%$9.58M$9.51M0.0030Positive NewsSSYSunLink Health SystemsN/A$1.12+16.6%N/A+34.5%$7.88M$31.09M4.661,376Gap UpMGRXMangoceuticals0.5976 of 5 stars$1.51-3.5%N/A-95.4%$7.81M$620K-0.393Positive NewsACONAclarion2.2215 of 5 stars$7.02-3.6%$11,758.50+167,400.0%-99.7%$4.07M$50K0.007Positive NewsATIPATI Physical TherapyN/A$0.68flatN/A-88.4%$2.98M$741.86M-0.045,600DHACDigital Health AcquisitionN/A$0.81+3.6%N/A-49.4%$2.92MN/A0.002,021Gap UpVSEEVSee Health1.5734 of 5 stars$0.77-4.8%$5.00+548.5%-49.0%$2.78MN/A0.00N/AGap Down Related Companies and Tools Related Companies Basel Medical Group Competitors Marpai Competitors Concord Medical Services Competitors BioNexus Gene Lab Competitors SunLink Health Systems Competitors Mangoceuticals Competitors Aclarion Competitors ATI Physical Therapy Competitors Digital Health Acquisition Competitors VSee Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BRTX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biorestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biorestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access